Unknown

Dataset Information

Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.


ABSTRACT:

Background

Most patients with pancreatic cancer develop cachexia, which is characterized by progressive muscle loss. The mechanisms underlying muscle loss in cancer cachexia remain elusive. Pancreatic tumour organoids are 3D cell culture models that retain key characteristics of the parent tumour. We aimed to investigate the effect of pancreatic tumour organoid-derived factors on processes that determine skeletal muscle mass, including the regulation of muscle protein turnover and myogenesis.

Methods

Conditioned medium (CM) was collected from human pancreatic cancer cell lines (PK-45H, PANC-1, PK-1, and KLM-1), pancreatic tumour organoid cultures from a severely cachectic (PANCO-9a) and a non-cachectic patient (PANCO-12a), and a normal pancreas organoid culture. Differentiat

SUBMITTER: Vaes RDW 

PROVIDER: S-EPMC8977981 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature